SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950162-11-000023
Filing Date
2011-01-14
Accepted
2011-01-14 14:43:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 REGENEX-SINAF 13D/A NO. 16 sinaf13dano16_011411.htm SC 13D/A 380780
  Complete submission text file 0000950162-11-000023.txt   382836
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 11530017
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11-13, BOULEVARD DE LA FOIRE LUXEMBOURG N4 L-1528
Business Address 11-13, BOULEVARD DE LA FOIRE LUXEMBOURG N4 L-1528 00352-26478360
Sinaf S.A. (Filed by) CIK: 0001495790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A